COMPASS Pathways partners with One Mind to fund Rising Star Awards for the next generation of mental health researchers
20 avr. 2022 07h00 HE
|
COMPASS Pathways
London, UK – 20 April 2022 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
Healios AG Announces Addition of Anna Walz to Board of Directors
12 avr. 2022 14h00 HE
|
Healios AG
BASEL, Switzerland, April 12, 2022 (GLOBE NEWSWIRE) -- Healios AG, a MedTech company focused on developing and validating digital biomarkers since 2014, announced that Anna Walz has been appointed...
The Liminal Platform Launches on Meta Quest
01 avr. 2022 12h55 HE
|
Liminal VR
Melbourne, Victoria, Australia, April 01, 2022 (GLOBE NEWSWIRE) -- The team at Liminal VR are excited to announce that the Liminal Platform will be launching on the Meta Quest Store on the 7th of...
Neurona Therapeutics Presents Preclinical Data at the American Academy of Neurology (AAN) Annual Meeting from Lead Cell Therapy Candidate, NRTX-1001, Being Evaluated in a Phase 1/2 Clinical Trial for Chronic Focal Epilepsy
01 avr. 2022 08h00 HE
|
Neurona Therapeutics
SAN FRANCISCO, April 01, 2022 (GLOBE NEWSWIRE) -- Neurona Therapeutics, a clinical-stage biotherapeutics company advancing regenerative cell therapies for the treatment of neurological disorders,...
Neuroscience Market Size Estimates and Forecasts [2022-2027] | In-Depth Analysis of Market Status, Growing CAGR of 3.5%, Industry Share, Emerging Trends, Production Capacity, Revenue, Price, Gross Margin and Cost Structures
30 mars 2022 05h34 HE
|
Industry Research
Pune, March 30, 2022 (GLOBE NEWSWIRE) -- “Final Report will add the analysis of the impact of COVID-19 on this industry." Global “Neuroscience Market” is a comprehensive research that provides...
XCPCNL Business Services Announces LOI to Acquire Centiment Capital Holdings
15 mars 2022 08h00 HE
|
XCPCNL Business Services Corporation
Charlotte, North Carolina, March 15, 2022 (GLOBE NEWSWIRE) -- XCPCNL Business Services Corporation (OTC Pink: XCPL), a venture development business that leverages knowledge, skill, and experience in...
Dr. David Margulies and Dr. Hal C. Lewis Present HEALING and REGENERATING the INJURED BRAIN
19 janv. 2022 14h00 HE
|
The Dan Lewis Foundation for Brain Regeneration Research
DENVER, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Talks at Google, a global talk series, recently presented Healing and Regenerating the Injured Brain with Dr. Hal Lewis and Dr. David Margulies. Drs. Lewis...
CenExel Clinical Research Acquires California Neuroscience Research
10 janv. 2022 13h10 HE
|
CenExel Clinical Research
Salt Lake City, Utah, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of California Neuroscience Research (“CenExel CNR”), a clinical...
Novartis announces U.S. Court of Appeals for the Federal Circuit (CAFC) upholds validity of Gilenya® (fingolimod) dosage regimen patent
04 janv. 2022 01h15 HE
|
Novartis Pharma AG
Basel, January 4, 2022 — Today, Novartis announced that the U.S. Court of Appeals for the Federal Circuit (CAFC) issued its decision upholding the validity of US Patent No. 9,187,405 covering a dosing...
Neurona Therapeutics Presents Preclinical Data from Lead Cell Therapy Candidate NRTX-1001 at Neuroscience 2021
08 nov. 2021 08h00 HE
|
Neurona Therapeutics
IND cleared by the FDA to enable initiation of Phase 1/2 clinical trial of NRTX-1001 in people with drug-resistant focal epilepsy Supporting preclinical data demonstrate seizure-freedom in up to 68%...